1,4-Phenylene dipropionate

We are 1,4-Phenylene dipropionate CAS:7402-28-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 7402-28-0
Product Name: 1,4-Phenylene dipropionate
Other Name:
1,4-Phenylene dipropionate
1,4-Dipropionyloxybenzene
 
Density: 1.124g/cm3
Boiling Point: 313.9ºC at 760 mmHg
Melting Point: 112-114°C
Molecular Formula: C12H14O4
Molecular Weight: 222.23700
Flash Point: 152.6ºC
Exact Mass: 222.08900
PSA: 52.60000
LogP: 2.31740
Index of Refraction: 1.5
 
Specification
Appearance: White or milky white flaky crystal
Assay: ≥98.0%
Melting point: 111 ~ 116 ℃
Heavy metal ppm: ≤2
Loss on drying: ≤1%
Residue on ignition: ≤1%
 
Application
Applicationd as a daily chemical raw material, and also used in whitening and freckle cosmetics.
Inhibits the activity of tyrosinase, inhibits or reduces the formation of skin melanin, thereby lightening the spots and whitening the skin. The esterified hydroquinone has good stability, has no irritation to the skin, and has no toxic or side effects. It is suitable for freckles, melasma, sunburn, melanin deposition on the skin, etc.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1,4-Phenylene dipropionate


Related News: At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.4-Isopropylthioxanthone CAS:83846-86-0 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.4-Nitrobenzyl Chloroformate Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.55453-89-9 Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.

Related Products
Product Name
N,N-dimethylformamide View Details
4FDCTZ View Details
1-Bromoheptane View Details
3-Amino-1-adamantanol manufacturer 2-Amino-4-chlorobenzoic acid manufacturer 1-Acetyl-2-imidazolidinone manufacturer 2-acetylfuran manufacturer tert-butyl 4-(2-ethoxycarbonyl-1-benzofuran-5-yl)piperazine-1-carboxylate manufacturer